Pressemitteilung BoxID: 845425 (VSY Biotechnology BV)
  • VSY Biotechnology BV
  • Strawinskylaan 1143
  • 1077 XX Amsterdam
  • Ansprechpartner
  • Berna Ozel Guvensan
  • +31 (20) 78200-01

VSY filled opposition against Zeiss patent

(PresseBox) (Amsterdam, ) VSY Biotechnology B. V. (VSY) has, amongst others, filed an opposition against Carl Zeiss Meditec A.G.’s (Zeiss) European patent EP 2 377 493 B1 “Method for manufacturing aphakic intraocular lens” (EP’493) with the European Patent Office (EPO) on May 6, 2016. Zeiss acquired EP’493 from the German IP advisers IP Strategists GmbH who acquired the patent from the Japanese company Menicon Co..VSY is of the opinion that EP’493 does not fulfil the requirements of patentability as it lacks novelty and inventive step, is insufficiently disclosed and includes extension of subject matter.

The patent regards Trifocal intraocular lenses. Trifocal lenses of Zeiss are AT LISA tri and the AT LISA tri toric.

The opposition is still pending.

All details of the opposition can be found on:

VSY Biotechnology BV

VSY Biotechnology is one of the leading companies in Industry of ophthalmology focusing on cataract surgery, producing premium intra ocular lenses and viscoelastic. For more information, please visit company website.